Topline results from the phase 2/3 XIRIUS study of cotoretigene toliparvovec (BIIB112), a gene therapy being investigated as a one-time therapy for patients with X-linked retinitis pigmentosa (XLRP), found that the study did not meet its primary endpoint of demonstrating a statistically significant improvement in the proportion of treated study eyes.
Individuals who took probiotics during the 6-month-long study had a 27% lower overall incidence of upper respiratory tract symptoms compared to the placebo group.
Although the opioid epidemic is a broad societal problem, health systems can play a critical role in the response.
When a patient recovering from gonorrhea was fed the powder of the kuchila molung plant, the patient quickly suffered from much more than painful urination.
The study authors said that treating the condition has been difficult until now due to a lack of FDA-approved therapies.
Treatment options include medications and recommendations to improve hygiene.
Guillermo Rodriguez Navarrete, the founder and CEO of Nutrillermo, and Elaine Ladd, the chief pharmacy officer of Pharmacy Development Services (PDS), discuss challenges pharmacists may face while expanding into the health and wellness space.
Guillermo Rodriguez Navarrete, the founder and CEO of Nutrillermo, and Elaine Ladd, the chief pharmacy officer of Pharmacy Development Services (PDS), discuss the 2021 Virtual PDS Conference session on growth opportunities in the health and wellness space for pharmacy.
Simko discussed how to retain new patients to continue to bring in new opportunities and better results for pharmacies everywhere.
Pharmacy Times spoke with Lauren Simko, managing performance specialist at Pharmacy Development Services, about her presentation "Elevated Patients Experiences: Lengthen the Patient Lifecycle to Increase Revenue."
Hannah Fish, PharmD, associate director of strategic initiatives at NCPA, discusses the role of the pharmacist in vaccinating children ages 12 and older against COVID-19 following the FDA updating the Pfizer COVID-19 vaccine EUA.
Median disease-free survival was twice as long in patients who received nivolumab compared to patients who received a placebo.
Locally advanced head and neck cancer represents a group of diseases that have seen few new treatment options over the past 20-plus years
In addition to improving health care access for patients, point-of-care testing in pharmacies can drive customer demand and satisfaction.
Vaccines that specifically target the receptor-binding domain of SARS-CoV-2 could be effective, as well as easy to manufacture and scale up.
The percentage dropped to only about 25% among people at a low genetic risk for the disease.
Melanoma forms when pigment-producing cells called melanocytes mutate and multiply uncontrollably.
Despite the stressors of the past year, students said the health care crisis has only reinforced the value of the pharmacist and their desire to enter the field.
Pharmacists can play a vital role in testing to improve medication outcomes in different practice settings.
It is important for pharmacists to understand the relationship between medication adherence and patient outcomes.
Melphalan flufenamide (Pepaxto; melflufen) is approved for use in combination with dexamethasone to treat adult patients with relapsed or refractory multiple myeloma.
Recent surveys have found high rates of occupational burnout among hematology and oncology pharmacists, with more than half or survey respondents reporting burnout.
Matthew Harms, a medical consultant and care center director at the MDA and associate professor of neurology at Columbia University Medical Center, to discuss new treatments and anticipated developments for ALS over the next year.
The technology demonstrates the important role students can play in pushing the pharmaceutical industry forward.
Blood eosinophil counts and FeNO levels are 2 key inflammatory biomarkers used by clinicians to inform treatment options and were defined as blood eosinophil count and FeNO.
The norepinephrine reuptake inhibitor indicated for patients aged age 6 to 17 years recently received FDA approval.
The primary endpoint of organ failure or death was 11.2% for those receiving dapagliflozin compared to 13.8% for those receiving the placebo.
A combination immunotherapy of interleukin-21 (IL-21) and interferon alpha (IFN-alpha) in combination with antiretroviral therapy (ART) is effective in generating highly functional natural killer (NK) cells that can help control and reduce simian immunodeficiency virus (SIV) in animal models.
Smart agent systems designed to automate insulin dose selection for critically ill patients could potentially optimize the safety and efficiency of insulin infusion practices in intensive care unit settings, according to a study published in BMJ Quality & Safety.
Heart failure can involve multiple factors, but heart muscle scarring is thought to be an important contributing factor in up to two-thirds of patients with HFpEF.
